ChemicalsLarge capRs 167,835 crRs 166.9 cr traded a dayManufacturingCommodities
Close on 2026-08-21
1,649.00
−0.66%
52-week range88% of the way up
1,273.601,701.50
Market cap
167,835 cr
P/E (TTM)
62.7×
industry 36×
EPS (TTM)
26.29
Revenue YoY
+21.3%
Q1 FY27
Profit YoY
+30.3%
Net margin
19.4%
+1.3pt vs a year ago
Growth trend
+7.2pt
vs last quarter’s YoY
1 month
+5.4%
Below 52w high
3.2%
RSI (14)
51
Daily swing
1.8%
average true range
Volume
0.7×
vs 20-day average
Traded
Rs 167 cr
median day
Close200-day averageMaterial filing
260 sessions · hover for the filing behind a move
1 week
−2.60%
1 month
+5.42%
3 months
+11.53%
6 months
+8.71%
1 year
+5.47%
The read
written from the numbers on this page
The evidence leans constructive8 supporting, 2 against, 0 worth knowing
Supporting
trading 11% above its 200-day average
sitting at 88% of its 52-week range, with little overhead supply from trapped buyers
up 5% over twelve months
matches the market's strongest stocks, which has beaten the market by +0.37 points over 20 sessions across 48,607 past signals
4 independent kinds of evidence agree today, which is uncommon
revenue grew 21% year on year in the quarter ending 2026-06-30
net margin has widened from 16.4% to 19.4% across four quarters
futures show a long buildup — the move is being funded by new positions
Against
1 of the scans it matches has historically underperformed the market
priced at 63× earnings against an industry median of 36× — 74% above its peers
Worth knowing
nothing the data supports either way
PIDILITIND sits in Manufacturing, Commodities — worth checking whether the whole group is moving together or whether this name is doing it alone.
What would change this read: a close below 1,481, its 200-day average; a failure to hold the top of its 52-week range; open interest reversing while price keeps going.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
read from the filings, with the figure behind every line
Working3
Profit rose year on year in all 4 of the last 4 quarters.
4
Net profit +30.3% year on year, Rs 678 cr to Rs 884 cr.
+30.3%Rs 678 crRs 884 cr
Revenue +21.3% year on year, Rs 3,753 cr to Rs 4,552 cr.
+21.3%Rs 3,753 crRs 4,552 cr
Needs watching
Nothing in the filings stands out either way.
Every figure here is computed from the company’s own filings. The wording is generated directly from the figures.
How it has performed
price return over each window, measured against zero
What the scans say today
10 of 47 matched on 2026-08-21
PIDILITIND matches 10 of the 47 scans today, across 4 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
PIDILITIND trades at 63× trailing earnings, below its median of 70× over this window — 11% less expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
Other filing filings were typically -0.08pt vs the market over the next 5 sessions (n=12,093) · AGM / EGM filings were typically +0.00pt vs the market over the next 5 sessions (n=4,362) · Analyst call filings were typically +0.14pt vs the market over the next 5 sessions (n=3,352)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 21% against the same quarter a year earlier
profit rose 30% year on year
net margin widened from 16.3% to 19.4%
Going against it
nothing clear in the filed numbers
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
2026-06-30 · consolidated
4,552
1,190
884
8.57
19.4%
Q4 FY26
2026-03-31 · consolidated
3,583
779
584
5.69
16.3%
Q3 FY26
2025-12-31 · consolidated
3,710
840
624
6.07
16.8%
Q2 FY26
2025-09-30 · consolidated
3,554
788
585
5.69
16.4%
Q1 FY26
2025-06-30 · consolidated
3,753
916
678
13.22
18.1%
Q4 FY25
2025-03-31 · consolidated
3,141
577
428
8.30
13.6%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+2.2%
Versus 200-day average+11.3%
Below 52-week high-3.1%
Above 52-week low+29.5%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)51.4
Higher closes in last 52 of 5
Six-month return+8.71%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)1.82%
Volume versus 20-day0.7x
Median daily turnoverRs 166.9 cr
Derivatives
near expiry 2026-08-25 · 2026-08-20
Long Buildup
Price up, open interest up. New buyers are arriving rather than old sellers leaving — the move is being funded, not squeezed.
Futures basis versus spot+0.10%
Open interest change+1.1%
Put / call ratio0.87
Put wall (support)1,600
Call wall (resistance)1,700
Max pain1,660
How to read this
Open interest is contracts still open, so a rise means new positions and a fall means positions closing. Combined with price direction that gives the state on the left. The walls are the strikes carrying the most open interest near expiry — levels other people are watching, not levels the price is obliged to respect. A future below spot means sellers are paying to be short.
Peers
Chemicals · 44 classified companies
PIDILITIND trades at 62.7× trailing earnings against an industry median of 36.0× across 41 other classified companies in its industry — more expensive than them, by 74%. A multiple is a statement about expectations, not about quality: cheap usually means the market expects less, and it is often right.
largest twelve by market capitalisation. Market cap and P/E need filed financials, so blanks are companies whose filings have not been read yet
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.